flutamide has been researched along with palladium in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behar, RJ; Cantor, A; Chovnick, SD; Huff, W; Otheguy, J; Perez, R; Sharkey, J; Solc, Z | 1 |
Behar, RJ; Cantor, A; Chovnick, SD; Donohue, M; Huff, W; Otheguy, J; Perez, R; Rabinowitz, R; Sharkey, J; Solc, Z; Steele, J; Webster, C | 1 |
Stock, RG; Stone, NN | 1 |
Cahlon, O; Cesaretti, JA; Kollmeier, MA; Stock, RG; Stone, NN | 1 |
Burri, RJ; Cesaretti, JA; Ho, AY; Stock, RG; Stone, NN | 1 |
1 review(s) available for flutamide and palladium
Article | Year |
---|---|
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal | 2002 |
2 trial(s) available for flutamide and palladium
Article | Year |
---|---|
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, Conformal | 2002 |
Combined modality treatment in the management of high-risk prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Testosterone | 2004 |
3 other study(ies) available for flutamide and palladium
Article | Year |
---|---|
Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Ambulatory Care; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brachytherapy; Chemotherapy, Adjuvant; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Ultrasonography, Interventional | 1998 |
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Combined Modality Therapy; Flutamide; Humans; Leuprolide; Male; Middle Aged; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Ultrasonography | 2000 |
Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
Topics: Analysis of Variance; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Brachytherapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Iodine Radioisotopes; Leuprolide; Male; Nitriles; Palladium; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Relative Biological Effectiveness; Tosyl Compounds; Treatment Failure | 2009 |